Epstein Secrets

From: Ian Osborne <Mil Sent: Wednesday, July 25, 2012 1:27 PM To: Jeffrey Epstein Subject: FT Attachments: image001-3jpg; Untitled attachment 00186.htm; Loulou's.xlsx; Untitled attachment 00189.htm Fyi - =ditor in chief of th

: Wednesday, July 25, 2012 1:27 PM To: Jeffrey Epstein Subject: FT Attachments: image001-3jpg; Untit

il Sent: Wednesday, July 25, 2012 1:27 PM To: Jeffrey Epstein Subject: FT Attachments: image001-3jp

ect: FT Attachments: image001-3jpg; Untitled attachment 00186.htm; Loulou's.xlsx; Untitled attachment 00189.htm Fyi - =ditor in chief of the FT, Lionel Barber, is coming to my dinner =omorrow night. So I can have a quiet word on Jes if that makes =ense. Begin forwarded message: From: Miranda Evans Subje

ce, who are interested in the serious side to your work and are uninterested in the tabloid headlines. Some of the necessary steps are: Take down the Jeffrey Epstein Science and Jeffrey Epstein Philanthropy websites, and build a new site from scratch which explains your interests, your past funding, the scientists

of the necessary steps are: Take down the Jeffrey Epstein Science and Jeffrey Epstein Philanthropy websites

e world economy than to probe tabloid headlines. Those editors and columnists I tend to single out are Gerald Baker and Thorold Barker at the Journal Lionel Barber and John Gapper at the Financial Times, Andrew Sorkin and Hugo Lindgren at the Times, John Micklethwait and Matthew Bishop at the Economist, Josh Tyr

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

Professor, School of Law University of Colorado USA Almir Guilherme Chief Financial Officer Petroleo Brasileiro SA Brazil Barbassa Petrobras Lionel Barber Editor The Financial Times United Kingdom Roger Barnett Chairman and Chief Executive Officer Shaklee Corporation USA Nicholas Barr Professor

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

Professor. School of Law University of Colorado USA Almir Guilherme Barbassa Chief Financial Officer Petroleo Brasileiro SA Brazil Petrobras Lionel Barber Editor The Financial Times United Kingdom Roger Bamett Chairman and Chief Executive Officer Shaklee Corporation USA Nicholas Barr Professor

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

Professor. School of Law University of Colorado USA Almir Guilherme Barbassa Chief Financial Officer Petroleo Brasileiro SA Brazil Petrobras Lionel Barber Editor The Financial Times United Kingdom Roger Bamett Chairman and Chief Executive Officer Shaklee Corporation USA Nicholas Barr Professor

John K. Defterios John J. DeGioia Alain Dehaze Jeffrey Deitch Marijn E. Dekkers Michael S. Dell Chris

ajit Banerjee Bang Han-Hong Manvinder S. Banga Britt D. Banks Hany El Benne Albert-Laszlo Barabasi Ehud Barak Sherif Barakat Almir Barbassa Lionel Barber Patricia Barbizet Gustavo Barbosa Thorold Barker Roger Barnett Michel Bernier Ornella Barra Nicolas Barre Maria Bartiromo Dominic Barton Ka

zli Ban Ki-moon Stéphane Bancel Oriana Bandiera Chandrajit Banerjee Shumeet Banerji Manvinder S. Banga Britt D. Banks Almir Guilherme Barbassa Lionel Barber Roger Barnett Nicholas Barr Nicolas Barré Maria Bartiromo Dominic Barton Pius Baschera Lluis Bassets Sonja Bata Olivier Baube Raymond J. Baxter E

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco